No Detail Found!

Monocyte Lymphocyte Ratio as a Possible Prognostic Marker in Antituberculous Therapy

Author(s)
Sumaira Iqbal Department of Physiology, Army Medical College, Rawalpindi, Pakistan.
Umbreen Ahmed Department of Physiology, Army Medical College, Rawalpindi, Pakistan.
Syed Badshah Hussain Zaidi Department of Medicine, Military Hospital, Rawalpindi Pakistan.
Abstract
Background :To assess monocyte lymphocyte ratio (M/L ratio) as a biomarker to see the outcome of therapy and progress of tuberculosis. Methods: In this descriptive study 45 newly diagnosed cases of tuberculosis and 45 age and sex matched healthy controls, were enrolled. The study was designed to determine the baseline, initiation phase and 2-months maintenance phase treatment values of M/L ratio in newly diagnosed active TB cases. Blood complete counts were performed in automated haematology analyzer. Manual differential leukocyte count was done by microscopy to determine M/L ratio. Results: The pre-treatment lymphocyte and monocyte count in the study group were significantly different from the control group, while M/L ratio was similar in both the groups. The mean M/L ratio in cases and controls were 0.24 ± 0.14 and 0.24 ± 0.07 respectively. The M/L ratio significantly decreased after initiation phase and two months of maintenance phase of treatment from baseline 0.24 ± 0.14 to 0.20 ± 0.10 to 0.19 ± 0.10 with p value of 0.006. Conclusions: Tuberculosis is associated with increased M/L ratio, which declines and returns to normal with antituberculous therapy.
Publication Details
Page(s) 178-181
DOI DOI not available
Published Journal: Journal of Rawalpindi Medical College, Volume: 18, Issue: 2, Year: 2014

Request the full text from PASTIC

Keywords
Antituberculous Therapy, Monocyte Lymphocyte Ratio
0

Citations

0

Downloads

51

Views